Navigation Links
Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets
Date:7/15/2008

rals and is the fourth most common cause of cancer mortality worldwide.

"Having followed the development of MammaPrint and CupPrint, we are excited about the opportunity for Ferrer inCode to expand the commercialization of these gene expression profiling tools in these four European countries," said Dr. Carlos de Lecea, vice president, International and Business Development at Ferrer. "Both tests provide valuable information that can be used to guide the therapeutic decision making process of oncologists, opening the door to a more personalized treatment for cancer patients."

The companies are also discussing the possibility of future cooperation and expansion into other parts of the world.

About Ferrer inCode and Grupo Ferrer Internacional

Ferrer inCode is the biotech subsidiary of Grupo Ferrer Internacional, working specifically in the field of personalized medicine as a provider of diagnostic orientation, prognosis and prediction services based chiefly on genomics, proteomics, metabolomics and bioinformatics. The vision of Ferrer inCode is to help doctors make the most accurate clinical decisions for every patient through advanced biotechnological services. Grupo Ferrer Internacional is a privately held European R&D-based pharmaco-chemical and medical device company headquartered in Barcelona, Spain. Ferrer operates today in over 60 countries with the overall aim of improving people's health and quality of life. Based on its policy of continuous expansion throughout the world, Ferrer has established strong industrial and commercial operations in Europe and has extensive commercial experience in Latin America, Africa, the Middle East and Far East. For more information on Ferrer, visit http://www.ferrergrupo.com or http://www.ferrerincode.com.

About Agendia

Agendia, located in Amsterdam, The Netherlands, is a world
'/>"/>

SOURCE Agendia BV
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Agendia BV Appoints Mr. Hessel Lindenbergh as Chairman of its Supervisory Board
2. Agendia Joins the Personalized Medicine Coalition (PMC)
3. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
4. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
5. Agendia BV Appoints Clinical and Scientific Advisory Board
6. Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement
7. Agendias MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform
8. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Dr. Kerry Solomon announced that he ...nched his redesigned website at www.DrKerrySolomo...Group. Dr. Solomon is a proven LASIK, lens implan...sionally recognized for his substantial contributi... a member of Trusted LASIK Surgeons, which screens...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlinke...is available in its catalogue: ,, Chromium - ...ker.com/p0164494/Chromium---Global-Market-Trends.h...ily influenced by stainless steel, while growth in...lso important for growth of chromium metal. Enviro...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlinke...is available in its catalogue: ,, Emerging Cli...amics and the changing healthcare and regulatory e...65658/Emerging-Clinical-Trial-Locations---Eastern-...-and-regulatory-environment.html ,, Over the l...
(Date:12/1/2009)... , CAMBRIDGE, Mass., Dec. 1 To...dustry and to promote its potential, a group of in... the Synthetic Biology Industry Association (SynBI... of the association is to provide a forum for indi...w industry, address its opportunities and its chal...
Breaking Biology Technology:Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2
...ZEMAN, Mont., March 18 LigoCyte Pharmaceuticals,I...ced that the company has,successfully finalized an...cing round to further clinical development of its ..., The private equity investment is being led by F...ith significant participation from Fidelity,Biosci...
...nge, DuPont Alliance on Track to Deliver First Bio...nsumer Benefits, DES MOINES, Iowa, March 18 New ...n oil trait from DuPont (NYSE: DD ),will deliver ...ations than,other soybean oil products currently o...the next generation of improved oil products devel...
...LUMBIA, Md., March 18 Martek Biosciences,(Nasdaq:...read product with,life,sDHA(TM), its patented, veg...rt health. The first and only U.S. bread with vege...om Bimbo Bakeries USA is now,available at major re...ona,and Nevada., "This new launch from Bimbo Bake...
Other Biology Technology:LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series 'C' Financing Round 2LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series 'C' Financing Round 3Research Confirms Better Oil from New DuPont High Oleic Soybean Trait 2Research Confirms Better Oil from New DuPont High Oleic Soybean Trait 3Martek Announces Launch of Oroweat 9 Grain Bread, First Bread with Martek's life'sDHA 2Martek Announces Launch of Oroweat 9 Grain Bread, First Bread with Martek's life'sDHA 3
(Date:12/2/2009)...ndhand smoke for a prolonged period of time and in...cer, even in women who never smoked cigarettes the... side-stream smoke could increase risk of breast c...lds, Ph.D., senior research scientist at the North...hile no single epidemiologic study can answer the ...
(Date:12/2/2009)...utter, and other foods have done more than raise p...y also are quietly fueling a boom in the market fo...fety regulations. That,s the topic of the two-part...ngineering News , (C&EN) ACS, weekly newsmagazine....ior Correspondent Marc Reisch point out that food ...
(Date:12/2/2009)...cal Center researchers have figured out how stem c...etter able to resist radiation therapy. And using ...these cancer stem cells, they were able to kill ma...y experiment. , The work builds off earlier res...he effects of radiation much better than other can...
Breaking Biology News(10 mins):Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Discovery makes brain tumor cells more responsive to radiation 2Study Estimates Medical Cost of Obesity May Be As High as 24147 Billion Annually 52790 1Study Estimates Medical Cost of Obesity May Be As High as 24147 Billion Annually 52790 2Study Estimates Medical Cost of Obesity May Be As High as 24147 Billion Annually 52790 3Scientists Track Impact of DNA Damage in the Developing Brain 52786 1Scientists Track Impact of DNA Damage in the Developing Brain 52786 2Scientists Track Impact of DNA Damage in the Developing Brain 52786 3Scientists Track Impact of DNA Damage in the Developing Brain 52786 4Department of Aging Urges Citizens to Report Abuse and Neglect of Older Adults 52784 1Department of Aging Urges Citizens to Report Abuse and Neglect of Older Adults 52784 2
...s in the,brain as a treatment for Parkinson diseas...ago, however the field is still in its infancy.,Re...t,dopamine-producing neurons (DA neurons) generate...d into areas of the brain where these neurons,have...e, can reverse,parkinsonism. Their results appear ...
...per about microarray-based experiments,reproducti...an I trust,these results? If I redo the same exper...? The NIH recently demonstrated that microarrays ... high degree of reproducibility , as long as stand...ews for the scientific community (and the microarr...
... a “cautionary tale?about what may go wrong when u... a diagnostic test for cancer. , In the February ...titute, researchers from The University of Texas M...ntal test intended to identify early ovarian cance... to a reliable clinical test right away. , After ...
Other Biology News:Transplantation Of Monkey Embryonic Stem Cells Reverses Parkinson Disease In Primates 2Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible 2Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible 3Another Look Finds Promising Proteomics Test is Not Biologically Plausible 2Another Look Finds Promising Proteomics Test is Not Biologically Plausible 3
Chicken Anti-Escherichia coli YebU Polyclonal Antibody, Unconjugated from Abcam
Jurkat Cell Slide from ProSci, Inc
...h Signet Level 2 Detection System combines the ind...al bonding principle and Signets unique formulatio...ecificity and reliablility. Signet reagents will a...nual and automated protocols. ,Signets USA Detec...
...h Signet Level 2 Detection System combines the ind...al bonding principle and Signets unique formulatio...ecificity and reliablility. Signet reagents will a...nual and automated protocols. ,Signets USA Dete...
Biology Products: